무료 바카라사이트 Biome rebrands as 무료 바카라사이트 Longevity to pursue global anti-a무료 바카라사이트ng initiatives

[by Lee, Young Sung] GI Biome, a novel drug development company affiliated with GI Innovation, has rebranded as ‘GI Longevity,’ signaling its ambition to lead the global anti-aging biotechnology market. Approved at the shareholders' meeting on August 8, the name change marks a significant transformation in the company's identity and business model.

GI Longevity has showcased the potential of ‘GIB-7,’ developed with its proprietary microbiome technology, as an anti-aging treatment in preclinical and clinical trials. The treatment has demonstrated efficacy in improving muscle strength, enhancing sleep quality in the elderly, and boosting postoperative quality of life in colorectal cancer patients.

GI Biome, together with its affiliate GI Innovation, was recognized for its innovation and potential at the XPRIZE Healthspan, a prestigious global science and technology competition. Out of approximately 600 teams worldwide, they ranked among the top 40, with only eight teams granted the opportunity to present their technologies and vision on the New York IR stage, leaving a strong impression on global investors and biotech industry insiders with the promise of next-generation anti-aging technology. The two companies are now preparing clinical trials in Australia and Korea to evaluate the combination therapy of ‘GI-102 (an immunotherapy)’ and ‘GIB-7 (a microbiome complex)’ in elderly patients.

GI Longevity adopted its new name to reflect its ambition to spearhead a global medical paradigm shift toward ‘healthy lifespan extension,’ building on its research achievements, strong interest from global investors, and the technologies and expertise of its affiliates, including GI Innovation. Alongside this rebranding, the company is developing an additional pipeline of modalities aimed at enhancing immune function, cognitive performance, and muscle strength—core pillars of anti-aging. Moreover, it plans to maximize synergies by integrating the unique approaches of its affiliates, such as GI Innovation's low-dose ‘GI-102’ therapy and GI Cell's autologous ‘NK cell therapy,’ in pursuit of its goal of extending healthy lifespan.

The global anti-a무료 바카라사이트ng market is a rapidly expanding and largely untapped blue ocean. For instance, Altos Labs, a leading U.S. anti-a무료 바카라사이트ng biotechnology firm, garnered significant industry attention from its inception, securing about KRW 4.2 trillion (approximately USD 3 billion) in funding from Amazon founder Jeff Bezos and prominent Silicon Valley investors. Building on this investment momentum, 무료 바카라사이트 Longevity intends to actively attract global investment.

“This name change is not merely a rebranding but a milestone that publicly affirms our new corporate identity and strategic direction,” said Yang Bo-gie, CEO of GI Longevity, expressing her ambition. “By advancing to the XPRIZE finals next year, we will accelerate the commercialization and business development of technologies aimed at extending healthy lifespan and solidify our position as a leading company in the global anti-aging industry.”